Synergistic Activity of Anticancer Polyphenols Embedded in Amphiphilic Dendrimer Nanoparticles
Source abstract
Abstract
Dendritic polymer nanoparticles (NPs) are promising vehicles for drug delivery. Most dendrimer polymer NPs, however, exhibit positive surface charge which make them, in many instances, cytotoxic. We constructed noncationic, amphiphilic dendrimer NPs embedding curcumin and resveratrol, natural polyphenols exhibiting anticancer properties. The curcumin/resveratrol/dendrimer NPs both effectively shielded the embedded polyphenols and facilitated their slow release and, notably, targeted cancer cells. The experimental data trace the cancer cell toxicity of the curcumin/resveratrol/dendrimer NPs to impairment of mitochondrial functions, specifically giving rise to enhanced intracellular calcium release, inhibition of cytochrome c oxidase enzyme activity, decreased mitochondrial membrane potential, and mitochondrial membrane perturbation. Importantly, synergism between the dendrimer-NP-embedded curcumin and resveratrol was observed, as more pronounced cancer cell death and mitochondrial disruption were induced by the curcumin/resveratrol/dendrimer NPs as compared to either the freely dissolved polyphenols or amphiphilic dendrimer NPs incorporating curcumin or resveratrol separately. This work suggests that amphiphilic dendrimer NPs encapsulating curcumin and resveratrol may constitute a promising anticancer therapeutic platform.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery · Synthesis and Characterization of Heterocyclic Compounds
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Ben-Gurion University of the Negev, Beer Sheva84105, Israel
Avram and Stella Goldstein-Goren Department of Biotechnology Engineering and the National Institute of Biotechnology, Ben-Gurion University of the Negev, Beer Sheva84105, Israel
Ilze Katz Center for Nanotechnology, Ben-Gurion University, Beer Sheva84105, Israel
Funding
Israel Science Foundation
References (93)
Show source-provided references
1. 10.1016/j.jtcme.2016.08.00210.1016/j.jtcme.2016.08.002 ↗
2. 10.1080/10408398.2016.126359710.1080/10408398.2016.1263597 ↗
3. 10.3390/nu1110237610.3390/nu11102376 ↗
4. 10.3892/etm.2018.634510.3892/etm.2018.6345 ↗
5. 10.1177/101042831769168010.1177/1010428317691680 ↗
6. 10.1111/nyas.1346610.1111/nyas.13466 ↗
7. 10.3390/molecules2424450610.3390/molecules24244506 ↗
8. 10.2174/156800961966619101914353910.2174/1568009619666191019143539 ↗
9. 10.1111/bcpt.1364810.1111/bcpt.13648 ↗
10. 10.1002/biof.177610.1002/biof.1776 ↗
11. 10.1159/00044784410.1159/000447844 ↗
12. 10.1080/01635581.2021.197783410.1080/01635581.2021.1977834 ↗
13. 10.14715/cmb/2017.63.11.1710.14715/cmb/2017.63.11.17 ↗
14. 10.3390/ijms2010245410.3390/ijms20102454 ↗
15. 10.1016/j.taap.2019.03.00810.1016/j.taap.2019.03.008 ↗
16. 10.1042/BSR2020025710.1042/BSR20200257 ↗
17. 10.1002/prot.2623810.1002/prot.26238 ↗
18. 10.1016/j.semcancer.2020.10.01010.1016/j.semcancer.2020.10.010 ↗
19. 10.1155/2021/266102510.1155/2021/2661025 ↗
20. 10.1208/s12249-019-1349-410.1208/s12249-019-1349-4 ↗
21. 10.1155/2016/975078510.1155/2016/9750785 ↗
22. 10.1002/adma.20210459410.1002/adma.202104594 ↗
23. 10.1016/j.ijpharm.2018.05.04510.1016/j.ijpharm.2018.05.045 ↗
24. 10.3390/molecules2209140110.3390/molecules22091401 ↗
25. 10.1016/j.drudis.2016.09.01310.1016/j.drudis.2016.09.013 ↗
26. 10.1016/j.apmt.2018.05.00210.1016/j.apmt.2018.05.002 ↗
27. 10.2174/138945012066619103109225910.2174/1389450120666191031092259 ↗
28. 10.1016/j.addr.2005.09.01810.1016/j.addr.2005.09.018 ↗
29. 10.1016/j.msec.2018.07.07010.1016/j.msec.2018.07.070 ↗
30. 10.1080/09205063.2020.182792110.1080/09205063.2020.1827921 ↗
31. 10.1021/acsabm.1c0074310.1021/acsabm.1c00743 ↗
32. 10.1016/j.addr.2021.11390810.1016/j.addr.2021.113908 ↗
33. 10.1016/j.msec.2017.07.05110.1016/j.msec.2017.07.051 ↗
34. 10.1021/jp905949g10.1021/jp905949g ↗
35. 10.1016/j.ijpharm.2011.01.02810.1016/j.ijpharm.2011.01.028 ↗
36. 10.1039/C4CC05279J10.1039/C4CC05279J ↗
37. 10.1007/s11095-017-2201-810.1007/s11095-017-2201-8 ↗
38. 10.1073/pnas.170472711410.1073/pnas.1704727114 ↗
39. 10.1088/0957-4484/24/3/03510310.1088/0957-4484/24/3/035103 ↗
40. 10.1039/c3cs60101c10.1039/c3cs60101c ↗
41. 10.1002/wnan.150410.1002/wnan.1504 ↗
42. 10.1007/s10895-011-0886-310.1007/s10895-011-0886-3 ↗
43. 10.1007/s10895-020-02574-310.1007/s10895-020-02574-3 ↗
44. 10.1038/s41598-020-62603-w10.1038/s41598-020-62603-w ↗
45. 10.1021/acs.jafc.0c0132610.1021/acs.jafc.0c01326 ↗
46. 10.1016/j.jconrel.2019.09.01610.1016/j.jconrel.2019.09.016 ↗
47. 10.1007/s00018-017-2496-y10.1007/s00018-017-2496-y ↗
48. 10.1007/s10555-018-09777-y10.1007/s10555-018-09777-y ↗
49. 10.15171/bi.2017.1510.15171/bi.2017.15 ↗
50. 10.2147/IJN.S17109910.2147/IJN.S171099 ↗
51. 10.1016/j.neulet.2021.13562810.1016/j.neulet.2021.135628 ↗
52. 10.1146/annurev-food-032818-12173810.1146/annurev-food-032818-121738 ↗
53. 10.1016/j.ejpb.2019.09.01610.1016/j.ejpb.2019.09.016 ↗
54. 10.1007/s10495-021-01689-710.1007/s10495-021-01689-7 ↗
55. 10.3390/biom1103039210.3390/biom11030392 ↗
56. 10.1002/biof.133810.1002/biof.1338 ↗
57. 10.1002/jcp.2812210.1002/jcp.28122 ↗
58. 10.1016/j.arcmed.2020.01.01010.1016/j.arcmed.2020.01.010 ↗
59. 10.3892/ijo.2017.385910.3892/ijo.2017.3859 ↗
60. 10.1161/CIRCRESAHA.116.30548410.1161/CIRCRESAHA.116.305484 ↗
61. 10.1016/j.bbrc.2016.11.08810.1016/j.bbrc.2016.11.088 ↗
62. 10.1016/j.bbabio.2017.01.00310.1016/j.bbabio.2017.01.003 ↗
63. 10.1016/j.bbabio.2017.01.00410.1016/j.bbabio.2017.01.004 ↗
64. 10.1016/j.bbrep.2019.10066710.1016/j.bbrep.2019.100667 ↗
65. 10.1002/adma.20200742610.1002/adma.202007426 ↗
66. 10.1016/j.semcdb.2017.08.05510.1016/j.semcdb.2017.08.055 ↗
67. 10.3748/wjg.v12.i35.562810.3748/wjg.v12.i35.5628 ↗
68. 10.1016/j.neuroscience.2009.04.04210.1016/j.neuroscience.2009.04.042 ↗
69. 10.1134/S000629791102007610.1134/S0006297911020076 ↗
70. 10.1016/j.ab.2017.07.00910.1016/j.ab.2017.07.009 ↗
71. 10.1007/s10495-016-1333-310.1007/s10495-016-1333-3 ↗
72. 10.3390/ijms1605923610.3390/ijms16059236 ↗
73. 10.1371/journal.pone.009382010.1371/journal.pone.0093820 ↗
74. 10.3892/or.2013.231010.3892/or.2013.2310 ↗
75. 10.1007/s12263-010-0179-510.1007/s12263-010-0179-5 ↗
76. 10.1080/0163558090275226210.1080/01635580902752262 ↗
77. 10.1080/10408398.2020.179179410.1080/10408398.2020.1791794 ↗
78. 10.1016/j.bbamem.2018.10.01610.1016/j.bbamem.2018.10.016 ↗
79. 10.3390/mi1305064410.3390/mi13050644 ↗
80. 10.1007/978-1-0716-0920-0_2110.1007/978-1-0716-0920-0_21 ↗
81. 10.3390/ijms2108294510.3390/ijms21082945 ↗
82. 10.1007/s12013-020-00906-510.1007/s12013-020-00906-5 ↗
83. 10.1007/s12029-018-00186-610.1007/s12029-018-00186-6 ↗
84. 10.1080/01635581.2018.139770810.1080/01635581.2018.1397708 ↗
85. 10.3390/ijms2107236410.3390/ijms21072364 ↗
86. 10.1161/CIRCRESAHA.119.31630610.1161/CIRCRESAHA.119.316306 ↗
87. 10.1016/j.ijpharm.2017.08.06410.1016/j.ijpharm.2017.08.064 ↗
88. 10.1016/j.bbamem.2020.18347110.1016/j.bbamem.2020.183471 ↗
89. 10.3791/5207610.3791/52076 ↗
90. 10.21769/BioProtoc.334910.21769/BioProtoc.3349 ↗
91. 10.1002/cbic.20100001010.1002/cbic.201000010 ↗
92. 10.1016/j.jconrel.2005.09.03910.1016/j.jconrel.2005.09.039 ↗
93. 10.1016/j.bbabio.2020.14823710.1016/j.bbabio.2020.148237 ↗